| abstract |
The invention provides diagnostic screening tests that can be used to identify whether a patient is a good candidate for an implantable vagus nerve stimulation device. One or more analytes, such as a cytokine or inflammatory molecule, can be measured from a blood sample taken prior to implantation of a vagus nerve stimulator to determine the patient's responsiveness to vagus nerve stimulation. in treatment of an inflammatory disorder. |